cellular
• after dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoyl-phorbol-13-acetate (TPA) treatment
|
homeostasis/metabolism
• fewer skin tumors smaller than 4 mm after induction of squamous cell carcinoma (SCC) by dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoyl-phorbol-13-acetate (TPA)
• normal number of skin tumors larger than 4 mm after induction of SCC by DMBA and TPA
|
integument
• after dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoyl-phorbol-13-acetate (TPA) treatment
|
• after dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoyl-phorbol-13-acetate (TPA) treatment
|
neoplasm
• fewer skin tumors smaller than 4 mm after induction of squamous cell carcinoma (SCC) by dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoyl-phorbol-13-acetate (TPA)
• normal number of skin tumors larger than 4 mm after induction of SCC by DMBA and TPA
|